ASSEMBLY BIOSCIENCES, INC. (ASMB) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 40 days, typically, give or take 18 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Thu, Nov 12, 2026after close 43 8-K
Q1 FY2026Thu, May 7, 2026after close 37 8-K
Q4 FY2025Thu, Mar 19, 2026after close 78 8-K
Q3 FY2025Mon, Nov 10, 2025after close 41 8-K
Q2 FY2025Wed, Aug 6, 2025after close 37 8-K
Q1 FY2025Thu, May 8, 2025after close 38 8-K
Q4 FY2024Thu, Mar 20, 2025after close 79 8-K
Q3 FY2024Thu, Nov 7, 2024after close 38 8-K

What they guided beta

Q3 FY2026 "EX-99.1 Exhibit 99.1 Assembly Biosciences Reports Third Quarter 2026 Financial Results and Recent Updates – Initiated Phase 2 clinical study of ABI-6250 in patients with chronic hepatitis delta virus infection – – Exercised 40% U.S. Profit-Share option for the HSV helicase primase inhibitor program – – Received first $75 million collaboration extension fee from Gilead; cash runway projected into 2029 – SOUTH SAN FRANCISCO, Calif. – November 12, 2026 – Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral and liver diseas" exhibit
Q3 FY2026 "“This quarter, we rapidly advanced our liver disease program by initiating the Phase 2 study of ABI-6250 in chronic hepatitis delta virus and preparing for our Phase 2 study in cholestatic liver diseases, which we expect to begin in the first quarter next year,” said Jason Okazaki, chief executive officer and president of Assembly Bio." exhibit
Q3 FY2026 "The company’s cash position, together with the $75 million collaboration extension fee received from Gilead in November 2026 following the third anniversary of the collaboration agreement, is projected to fund operations into 2029." exhibit
Q1 FY2026 "Assembly Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights – Completed Phase 1b studies for ABI-5366 and ABI-1179, helicase-primase inhibitors for recurrent genital herpes – – Completed chronic toxicology studies for ABI-6250, an oral small-molecule entry inhibitor candidate for chronic hepatitis delta virus; Phase 2 initiation anticipated Q4 2026 – SOUTH SAN FRANCISCO, Calif. – May 7, 2026 – Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today reported financial results for th" exhibit
Q1 FY2026 "“As we look ahead, we anticipate receiving Gilead’s development plan and budget for the herpesvirus program and will evaluate our cost and profit share opt-in decision by mid-2026 while continuing to advance ABI-6250 toward Phase 2 in hepatitis delta virus by year-end.”" exhibit
Q1 FY2026 "Initiation of a Phase 2 clinical study for ABI-6250 in participants with chronic hepatitis delta virus (HDV) infection expected in the fourth quarter of 2026" exhibit
Q1 FY2026 "The company’s cash position is projected to fund operations into 2028." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/ASMB
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/ASMB

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

ASMB earnings date badge

HTML

<a href="https://veritasdata.dev/company/ASMB/"><img src="https://veritasdata.dev/embed/ASMB.svg" alt="ASMB earnings date" width="240" height="56"></a>

Markdown

[![ASMB earnings date](https://veritasdata.dev/embed/ASMB.svg)](https://veritasdata.dev/company/ASMB/)

Script

<script async src="https://veritasdata.dev/embed/ASMB.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/ASMB"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.